Tools for regulated gene expression in Enterococcus faecalis are extremely limited. In this report, we describe the construction of an expression vector for E. faecalis, designated pCIE, utilizing the P Q pheromone-responsive promoter of plasmid pCF10. We demonstrate that this promoter is tightly repressed, responds to nanogram quantities of the peptide pheromone, and has a large dynamic range. To demonstrate its utility, the promoter was used to control expression of the toxic peptides of two par family toxin-antitoxin (TA) loci present in E. faecalis, par pAD1 of the pAD1 plasmid and par EF0409 located on the E. faecalis chromosome. The results demonstrated differences in the modes of regulation of toxin expression and in the effects of toxins of these two related systems. We anticipate that this vector will be useful for further investigation of par TA system function as well as the regulated expression of other genes in E. faecalis. IMPORTANCE E. faecalis is an important nosocomial pathogen and a model organism for examination of the genetics and physiology of Gram-positive cocci. While numerous genetic tools have been generated for the manipulation of this organism, vectors for the regulated expression of cloned genes remain limited by high background expression and the use of inducers with undesirable effects on the cell. Here we demonstrate that the P Q pheromone-responsive promoter is repressed tightly enough to allow cloning of TA system toxins and evaluate their effects at very low induction levels. This tool will allow us to more fully examine TA system function in E. faecalis and to further elucidate its potential roles in cell physiology.KEYWORDS Enterococcus, expression vector, pheromone, toxin-antitoxin systems E nterococci have emerged over the past few decades as major nosocomial pathogens. They are responsible for 15% of health care-associated urinary tract infections (1), cause 5 to 15% of all infectious endocarditis cases (2), and are currently the second leading cause of health care-associated bacteremia (1). Treatment is complicated by intrinsic resistance to a variety of antibiotics and acquired resistance to high-level aminoglycosides, vancomycin, and other antibiotics (3). A variety of mobile genetic elements (MGE) facilitate the transfer of antibiotic resistance determinants (4). Enterococcus faecalis and Enterococcus faecium cause the majority of infections, with E. faecalis generally being more pathogenic and E. faecium displaying greater antibiotic resistance, particularly to vancomycin. E. faecalis has also emerged as a model organism for